APA (7th ed.) Citation

I, S., S, H., B, R., J, N., I, J., & L, J. (2026). Treatment with Mirvetuximab-Soravtansin-first clinical experience in advanced ovarian cancer in a comprehensive cancer center. Frontiers in oncology, 16, 1732304. https://doi.org/10.3389/fonc.2026.1732304

Chicago Style (17th ed.) Citation

I, Schwörer, Huwer S, Rautenberg B, Neubauer J, Juhasz-Böss I, and Jung L. "Treatment with Mirvetuximab-Soravtansin-first Clinical Experience in Advanced Ovarian Cancer in a Comprehensive Cancer Center." Frontiers in Oncology 16 (2026): 1732304. https://doi.org/10.3389/fonc.2026.1732304.

MLA (9th ed.) Citation

I, Schwörer, et al. "Treatment with Mirvetuximab-Soravtansin-first Clinical Experience in Advanced Ovarian Cancer in a Comprehensive Cancer Center." Frontiers in Oncology, vol. 16, 2026, p. 1732304, https://doi.org/10.3389/fonc.2026.1732304.